Download PDF
Planta Med 2013; 79(12): 1038-1042
DOI: 10.1055/s-0032-1328769
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

In Vitro BACE1 Inhibitory Activity of Geraniin and Corilagin from Geranium thunbergii

Kumju Youn
Department of Food Science and Nutrition, Dong-A University, Busan, Korea
,
Mira Jun
Department of Food Science and Nutrition, Dong-A University, Busan, Korea
› Author Affiliations
Further Information

Publication History

received 29 January 2013
revised 21 May 2013

accepted 15 June 2013

Publication Date:
22 July 2013 (online)

Also available at
    Permissions and Reprints

Abstract

Generation of amyloid β peptide through the proteolytic process of amyloid precursor protein by β-secretase and γ-secretase is a main casual factor of Alzheimerʼs disease, since amyloid β peptide is a major and crucial component of senile plaques in Alzheimerʼs disease brains. In the process of searching for β-secretase inhibitors from natural resources, the EtOAc soluble fraction of Geranium thunbergii exhibited significant β-secretase inhibitory activity. Two compounds, geraniin and corilagin, isolated from the most active EtOAc fraction of G. thunbergii, exhibited predominant inhibition against β-secretase with IC50 values of 4.0 × 10−6 M and 3.4 × 10−5 M, respectively. Dixon plot of geraniin and corilagin demonstrated that the β-secretase inhibition was noncompetitive with the substrate, thus clearly suggesting that these compounds might bind either to the β-secretase subsites or to another regulatory domain with Ki values of 2.8 × 10−6 M and 7.9 × 10−5 M, respectively. Both compounds exhibited no significant inhibition against α-secretase and other serine proteases including trypsin and chymotrypsin, showing that they were relatively specific and selective inhibitors of β-secretase. These novel findings suggest that geraniin and corilagin from G. thunbergii may be effective therapeutic agents for further drug development in Alzheimerʼs disease.

Key words

Alzheimerʼs disease - amyloid β peptide - β-secretase - Geranium thunbergii - Geraniaceae

Supporting Information

 

  • References

  • 1 Shimmyo Y, Kihara T, Akaike A, Niidome T, Sugimoto H. Flavonols and flavones as BACE1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. Biochim Biophys Acta 2008; 1780: 819-825
    CrossrefPubMedGoogle Scholar
  • 2 Jin H, Liu T, Wang WX, Xu JH, Yang PB, Lu HX, Sun QR, Hu HT. Protective effects of [Gly14]-humanin on β-amyloid-induced PC12 cell death by preventing mitochondrial dysfunction. Neurochem Int 2010; 56: 417-423
    CrossrefPubMedGoogle Scholar
  • 3 Efremov IV, Vajdos FF, Borzilleri KA, Capetta S, Chen H, Dorff PH, Dutra JK, Goldstein SW, Mansour M, McColl A, Noell S, Oborski CE, OʼConnell TN, OʼSullivan TJ, Pandit J, Wang H, Wei BQ, Withka JM. Discovery and optimization of a novel spiropyrrolidine inhibitor of β-secretase (BACE1) through fragment-based drug design. J Med Chem 2012; 55: 9069-9088
    CrossrefPubMedGoogle Scholar
  • 4 Luo Y, Bolon B, Kahn S, Bennett BD, Khan SB, Denis P, Fan W, Kha H, Zhang J, Gong Y, Martin L, Louis JC, Yan Q, Richards WG, Citron M, Vassar R. Mice deficient in BACE1, the Alzheimerʼs β-secretase, have normal phenotype and abolished β-amyloid generation. Nature 2001; 4: 231-232
    PubMedGoogle Scholar
  • 5 Wolfe MS. APP, notch and presenilin: molecular pieces in the puzzle of Alzheimerʼs disease. Int Immunopharmacol 2002; 2: 1919-1929
    CrossrefPubMedGoogle Scholar
  • 6 Liu QH, Jeong JE, Choi EJ, Moon YH, Woo ER. A new furofuran lignan from Geranium thunbergii Sieb. et Zucc. Arch Pharm Res 2006; 29: 1109-1113
    CrossrefPubMedGoogle Scholar
  • 7 Okuda T, Mori K, Seno K, Hatano T. Constituents of Geranium thunbergii Sieb. et Zucc.: VII. High-performance reversed-phase liquid chromatography of hydrolysable tannins and related polyphenols. J Chromatogr A 1979; 171: 313-320
    PubMedGoogle Scholar
  • 8 Ito H, Hatano T, Namba O, Shirono T, Okuda T, Yoshida T. Constituents of Geranium thunbergii Sieb. et Zucc. XV. Modified dehydroellagitannins, geraniic acids B and C, and phyllanthusiin F. Chem Pharm Bull 1999; 47: 1148-1151
    CrossrefPubMedGoogle Scholar
  • 9 Ushino Y, Okuda T, Abe H. Effects of geraniin on morphology and function of macrophages. Int Arch Allergy Immunol 1991; 96: 224-230
    CrossrefPubMedGoogle Scholar
  • 10 Hiramatsu N, Xiufen W, Takechi R, Itoh Y, Mamo J, Pal S. Antimutagenicity of Japanese traditional herbs, gennoshoko, yomogi, senburi and iwa-tobacco. Biofactors 2004; 22: 123-125
    CrossrefPubMedGoogle Scholar
  • 11 Sung YY, Yoon T, Yang WK, Kim SJ, Kim HK. Anti-obesity effects of Geranium thunbergii extract via improvement of lipid metabolism in high-fat diet-induced obese mice. Mol Med Report 2011; 4: 1107-1113
    PubMedGoogle Scholar
  • 12 Xiufen W, Hiramatsu N, Matsubara M. The antioxidative activity of traditional Japanese herbs. Biofactors 2004; 21: 281-284
    CrossrefPubMedGoogle Scholar
  • 13 Adesina SK, Idowu O, Ogundaini AO, Oladimeji H, Olugbade TA, Onawunmi GO, Pais M. Antimicrobial constituents of the leaves of Acalypha wilkesiana and Acalypha hispida . Phytother Res 2000; 14: 371-374
    CrossrefPubMedGoogle Scholar
  • 14 Marumoto S, Miyazawa M. β-Secretase inhibitory effects of furanocoumarins from the root of Angelica dahurica . Phytother Res 2010; 24: 510-513
    PubMedGoogle Scholar
  • 15 Youn K, Jun M. Inhibitory effects of key compounds isolated from Corni fructus on BACE1 activity. Phytother Res 2012; 26: 1714-1718
    CrossrefPubMedGoogle Scholar
  • 16 Dai J, Shen D, Yoshida W, Parrish S, Williams P. Isoflavonoids from Ficus benjamina and their inhibitory activity on BACE1. Planta Med 2012; 78: 1357-1362
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Park IH, Jeon SY, Lee HJ, Kim SI, Song KS. A β-secretase (BACE1) inhibitor hispidin from the mycelial cultures of Phellinus linteus . Planta Med 2004; 70: 143-146
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Je JY, Kim SK. Water-soluble chitosan derivatives as a BACE1 inhibitor. Bioorg Med Chem 2005; 13: 6551-6555
    CrossrefPubMedGoogle Scholar
  • 19 Ito H. Metabolites of ellagitannins and their antioxidant activity. Planta Med 2011; 77: 1110-1115
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Serrano J, Puupponen-Pimia R, Dauer A, Aura A, Saura-Calixto F. Tannins: current knowledge of food sources, intake, bioavailability and biological effects. Mol Nutr Food Res 2009; 53: S310-S329
    CrossrefPubMedGoogle Scholar
  • 21 Kwak HM, Jeon YS, Sohng BH, Kim JG, Lee JM, Lee KB, Jeong HH, Hur JM, Kang YH, Song KS. β-Secretase (BACE1) inhibitors from pomegranate (Punica granatum) Husk. Arch Pharm Res 2005; 28: 1328-1332
    CrossrefPubMedGoogle Scholar
  • 22 Prasain JK, Peng N, Dai Y, Moore R, Arabshahi A, Wilson L, Barnes S, Wyss JM, Kim H, Watts RL. Liquid chromatography tandem mass spectrometry identification of proanthocyanidins in rat plasma after oral administration of grape seed extract. Phytomedicine 2009; 16: 233-243
    CrossrefPubMedGoogle Scholar
  • 23 Tamagno E, Bardini P, Guglielmotto M, Danni O, Tabaton M. The various aggregation state of β-amyloid 1–42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. Free Radic Biol Med 2006; 41: 202-212
    CrossrefPubMedGoogle Scholar
  • 24 Thitilertdecha N, Teerawutgulrag A, Kilburn JD, Rakariyatham N. Identification of major phenolic compounds from Nephelium lappaceum L. and their antioxidant activities. Molecules 2010; 15: 1453-1465
    CrossrefPubMedGoogle Scholar
  • 25 Chen Y, Chen C. Corilagin prevents tert-butyl hydroperoxide-induced oxidative stress injury in cultured N9 murine microglia cells. Neurochem Int 2011; 59: 290-296
    CrossrefPubMedGoogle Scholar
  • 26 Okabe S, Suganuma M, Imayoshi Y, Taniguchi S, Yoshida T, Fujiki H. New TNF-α releasing inhibitors, geraniin and corilagin, in leaves of Acer nikoense, Megusurino-ki. Biol Pharm Bull 2001; 24: 1145-1148
    CrossrefPubMedGoogle Scholar